Machine learning model predicting axillary pathologic response after neoadjuvant chemotherapy for clinically node-positive breast cancer

被引：0
|
作者：
Matsumoto, A. [1 ]
Sugimoto, M. [2 ]
Naruse, S. [1 ]
Isono, Y. [1 ]
Maeda, Y. [1 ]
Sato, A. [1 ]
Yamada, M. [1 ]
Ikeda, T. [1 ]
Jinno, H. [1 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Surg, Tokyo, Japan
[2] Keio Univ, Grad Sch Media & Governance, Yokohama, Kanagawa, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113742
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
169 (PB-07
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [21] Predictive value of tumor response rate for axillary response of neoadjuvant chemotherapy in patients with clinically node-positive breast cancer
    Kim, H. S.
    Eom, Y. H.
    Yoo, T. K.
    Song, B. J.
    Chae, B. J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [22] Nomogram for predicting axillary lymph node pathological complete response in node-positive breast cancer patients after neoadjuvant chemotherapy.
    Wang, Wenyan
    Wang, Xin
    Wang, Xiang
    Liu, Jiaqi
    Zhang, Pin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] Predictors of axillary node response in node-positive patients undergoing neoadjuvant chemotherapy for breast cancer
    Ladak, Farah
    Chua, Natalie
    Lesniak, David
    Ghosh, Sunita
    Wiebe, Ericka
    Yakimetz, Walter
    Rajaee, Nikoo
    Olson, David
    Peiris, Lashan
    CANADIAN JOURNAL OF SURGERY, 2022, 65 (01) : E89 - E96
  • [24] A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer
    Kantor, Olga
    Sipsy, Lynn McNulty
    Yao, Katharine
    James, Ted A.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (05) : 1304 - 1311
  • [25] A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer
    Olga Kantor
    Lynn McNulty Sipsy
    Katharine Yao
    Ted A. James
    Annals of Surgical Oncology, 2018, 25 : 1304 - 1311
  • [26] Axillary lymph node dissection after neoadjuvant chemotherapy for node-positive breast cancer.
    Van Zeeland, M.
    Westhoff, P.
    Wauters, C.
    Bult, P.
    Werner, A.
    Laurens, N.
    Strobbe, L.
    Meijer, H.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S519 - S519
  • [27] Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node-positive breast cancer according to breast cancer subtype
    Maeshima, Yurina
    Sakai, Takehiko
    Ogiya, Akiko
    Takahashi, Yoko
    Miyagi, Yumi
    Kokubu, Yumi
    Osako, Tomo
    Ito, Yoshinori
    Takahashi, Shunji
    Ohno, Shinji
    Ueno, Takayuki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node-positive breast cancer according to breast cancer subtype
    Yurina Maeshima
    Takehiko Sakai
    Akiko Ogiya
    Yoko Takahashi
    Yumi Miyagi
    Yumi Kokubu
    Tomo Osako
    Yoshinori Ito
    Shunji Takahashi
    Shinji Ohno
    Takayuki Ueno
    Scientific Reports, 11
  • [29] Prognostic role of breast pathologic complete response after neoadjuvant chemotherapy in node-positive breast cancer patients
    Woo, J.
    Ryu, J. M.
    Lee, S. K.
    Yu, J.
    Lee, J. E.
    Kim, S. W.
    Nam, S. J.
    Chae, B. J.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S23 - S23
  • [30] Targeted Axillary Dissection for Patients Who Convert to Clinically Node Negative After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer
    Kandice Ludwig
    Amanda L. Kong
    Current Breast Cancer Reports, 2020, 12 : 391 - 397
12345